What is the most appropriate next step in the management?
belongs to book: Hematology Case Review|Donald C. Doll & Radwan F. Khozouz & Wes Matthew Triplett|| Chapter number:13| Question number:2
All Answers
total answers (1)
belongs to book: Hematology Case Review|Donald C. Doll & Radwan F. Khozouz & Wes Matthew Triplett|| Chapter number:13| Question number:2
total answers (1)
E. Mutations in JAK2 have been reported in approximately 50% of cases with myelofibrosis (NE]M. 2005;352(17):1 779, Blood. 2005;106(6):2162). Mutations in MPL gene have been reported in 5% of cases with myelofibrosis regardless of JAK2 mutational status and in approximately 10% of cases with JAK2 negative myelofibrosis. Test for BCR-ABL is required to rule out CML (Blood. 2006;108(10):3472, Br ] Haematol. 2010;149(2):250).
need an explanation for this answer? contact us directly to get an explanation for this answer